Cargando…
Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model
BACKGROUND: Using killed microorganisms or their parts to stimulate immunity for cancer treatment dates back to the end of 19(th) century. Since then, it undergone considerable development. Our novel approach binds ligands to the tumor cell surface, which stimulates tumor phagocytosis. The therapeut...
Autores principales: | Caisová, Veronika, Vieru, Andra, Kumžáková, Zuzana, Glaserová, Simona, Husníková, Hana, Vácová, Nikol, Krejčová, Gabriela, Paďouková, Lucie, Jochmanová, Ivana, Wolf, Katherine I., Chmelař, Jindřich, Kopecký, Jan, Ženka, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142338/ https://www.ncbi.nlm.nih.gov/pubmed/27927165 http://dx.doi.org/10.1186/s12885-016-2982-x |
Ejemplares similares
-
The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model
por: Janotová, Tereza, et al.
Publicado: (2014) -
Identification of Immune Cell Infiltration in Murine Pheochromocytoma during Combined Mannan-BAM, TLR Ligand, and Anti-CD40 Antibody-Based Immunotherapy
por: Uher, Ondrej, et al.
Publicado: (2021) -
Systemic Immune Response in Murine Bilateral Pheochromocytoma Model During Immunotherapy Based on a Combination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibodies (MBTA Therapy)
por: Uher, Ondrej, et al.
Publicado: (2021) -
The Significant Reduction or Complete Eradication of Subcutaneous and Metastatic Lesions in a Pheochromocytoma Mouse Model after Immunotherapy Using Mannan-BAM, TLR Ligands, and Anti-CD40
por: Caisova, Veronika, et al.
Publicado: (2019) -
Insight into the sialome of the castor bean tick, Ixodes ricinus
por: Chmelař, Jindřich, et al.
Publicado: (2008)